Publicaciones (37) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis

    Acta Dermato-Venereologica, Vol. 104

  2. A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 24, Núm. 2, pp. 227-235

  3. Agreement between the perception of colon cleansing reported by patients and colon cleansing assessed by a validated colon cleansing scale

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 2, pp. 130-139

  4. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 16-22

  5. Biomarkers in Alzheimer’s Disease: Are Olfactory Neuronal Precursors Useful for Antemortem Biomarker Research?

    Brain Sciences, Vol. 14, Núm. 1

  6. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population

    Nefrologia, Vol. 44, Núm. 1, pp. 77-89

  7. Comparative Study of Predictive Models for the Detection of Patients at High Risk of Inadequate Colonic Cleansing

    Journal of Personalized Medicine, Vol. 14, Núm. 1

  8. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

    Neurologia, Vol. 39, Núm. 2, pp. 196-208

  9. Cost-effectiveness Analysis of Single-Use Duodenoscope Applied to Endoscopic Retrograde Cholangiopancreatography

    Pancreas, Vol. 53, Núm. 4, pp. E357-E367

  10. Design and validation of an artificial intelligence system to detect the quality of colon cleansing before colonoscopy

    Gastroenterologia y Hepatologia

  11. Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 1

  12. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 1, pp. 39-50

  13. Home noninvasive ventilation in severe COPD: in whom does it work and how?

    ERJ Open Research, Vol. 10, Núm. 1

  14. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  15. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 1, pp. 51-60

  16. Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  17. Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation

    Actas Dermo-Sifiliograficas

  18. Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1

    Kidney International Reports, Vol. 9, Núm. 1, pp. 114-133

  19. Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers

    Antioxidants, Vol. 13, Núm. 2, pp. 156

  20. Postcolonoscopy colorectal cancer: Prevalence, categorization and root-cause analysis based on the World Endoscopic Organization system

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 319-326